Colorectal cancer patients with the UGT1A6 rs2070959 AA genotype may have an increased risk for severe neutropenia when treated with irinotecan compared to patients with the wild-type UGT1A6 rs2070959 GG genotype [83]. Here, UGT1A6 is linked to colorectal cancer.